Serial Number
79433974
Owner
Nordic Bioscience A/SAttorney
Bradley M. StohryFiling Date
Aug 14, 2025
NORDICCTX-III Trademark
Serial Number: 79433974
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Bradley M. Stohry Reichel Stohry Dean LLP
6151 Central Ave
Indianapolis, IN 46220
United States
Trademark Details
Filing Date
August 14, 2025
Registration Date
Not Registered
Published for Opposition
August 25, 2026
Goods & Services
Diagnostic biomarker reagents for medical purposes; biomarkers for use individually or in combination to detect tissue formation, tissue remodeling, or tissue destruction; diagnostic biomarker assays to identify disease activity for medical use; diagnostic biomarker assays for medical use to quantify disease activity; diagnostic biomarker assays for medical use to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for testing bodily fluids for use in disease detection, disease analysis and quantifying disease activity; diagnostic agents for medical use; diagnostic reagents for medical use; clinical diagnostic agents; clinical diagnostic reagents for medical use; diagnostic preparations, diagnostic substances and diagnostic materials for medical purposes; medical diagnostic test strips for testing samples for the presence of biomarkers; diagnostic preparations for medical purposes
Design and development of blood-based biomarker assays for the identification, quantification and analysis of disease activity; design and development of diagnostic biomarker reagents for medical purposes, for pharmaceutical purposes and for scientific purposes; design and development of biochemical and pharmaceutical assays and medical assays; design and development of biomarkers for individual use or combined for the tracking of tissue formation, development or tissue degradation; pharmaceutical and scientific research in the fields of biomarkers and the detection of biomarkers; medical research, namely, identification of predictive and prognostic biomarkers for clinical trials; medical research, namely, identifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services relating to clinical trials; scientific research in the nature of conducting clinical trials for others; medical research, namely, analysis of pharmacodynamic data; medical research, namely, analysis of data relating to biomarkers; development of diagnostic preparations for medical purposes, diagnostic equipment and diagnostic tests; medical research laboratory services relating to clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes; medical research services, namely, testing services relating to the tracking and measurement of biomarkers; medical research services, namely, testing samples for the presence of biomarkers; scientific laboratory services; medical research laboratory services; medical research laboratories; medical, pre-clinical, clinical, biological, biotechnological and pharmaceutical research services involving experimentation, development, and analysis